Acrivon Therapeutics, Inc. Common Stock (ACRV) — Defensive Interval Ratio
Acrivon Therapeutics, Inc. Common Stock (ACRV) has a Defensive Interval Ratio of 2300 days as of September 2025. Defensive assets of $93.85 Million (cash $-, short-term investments $93.85 Million, receivables $-) cover 2300 days of daily cash needs of $40.80K/day. Check Acrivon Therapeutics, Inc. Common Stock (ACRV) tangible net worth to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Acrivon Therapeutics, Inc. Common Stock Defensive Interval Ratio (2021–2024)
This chart shows how Acrivon Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the ratio stands at 2300 days, meaning defensive assets of $93.85 Million can fund 2300 days of operations without new revenue. Also explore how fast is Acrivon Therapeutics, Inc. Common Stock growing its equity to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Acrivon Therapeutics, Inc. Common Stock (2021–2024)
The table below presents the year-by-year Defensive Interval Ratio for Acrivon Therapeutics, Inc. Common Stock from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see ACRV stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 2961 days | $139.66 Million | $47.16K/day | $- | $139.66 Million | ▲ +452 days |
| 2023 | 2509 days | $91.44 Million | $36.45K/day | $- | $91.44 Million | ▼ -2994 days |
| 2022 | 5503 days | $98.23 Million | $17.85K/day | $- | $98.23 Million | ▲ +5503 days |
| 2021 | 0 days | $0.00 | $7.98K/day | $- | $0.00 | — |